Lewes, DE -- (SBWIRE) -- 07/08/2015 -- Hyaluronic acid (HA) is an anionic, nonsulfated glycosaminoglycan that is naturally present in the human body. It is mainly concentrated in fluids in the joints. Its function is to provide cushioning for joints. Individuals who suffer from osteoarthritis are deficient in these fluids. One of the treatment options for these patients is HA viscosupplementation injections.

Much like the BGS market, the HA market has been experiencing price erosion due to an increase in competition, especially in the German market; the price for a five-injection product in Germany had been reduced to a mere €60 for all five syringes. ASPs for all three cycle products are expected to decline mildly over the forecast period.

Spanning over 92 pages, 3 Charts and 3 Figures "Europe Markets for Hyaluronic Acid Viscosupplementation 2011-2021" report covers Research Methodology, Country Profiles, Hyaluronic Acid Viscosupplementation Market. This report Covered 10 Companies - Fidia, Sanofi, Smith & Nephew, Meda Pharma, TRB Chemedica, Laboratoire Genevrier, Recordati, Tedec Meiji, Croma-Pharma, Seikagaku.

For further information on this report, please visit- http://www.marketresearchreports.com/idata-research/europe-markets-hyaluronic-acid-viscosupplementation-2011-2021

Find all Treatments Reports at: http://www.marketresearchreports.com/treatments

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter